ExCeL London |  24 - 25 April 2024

14 Feb 2024

The world’s most advanced skin cancer pathways

Skin Analytics Hall: N7 - N10 Stand: A21
  • The world’s most advanced skin cancer pathways
  • The world’s most advanced skin cancer pathways
The world’s most advanced skin cancer pathways The world’s most advanced skin cancer pathways

Nationally, urgent suspected skin cancer referrals are increasing by more than 11% each year and without innovation, we cannot expect our dermatology teams to be able to achieve these targets in the future.

Despite the significant and sustained efforts from dermatology teams across the country, cancer wait time targets are not being met. Provisional NHS data suggests that at the end of 2022, 1 in 10 urgent skin cancer referrals waited more than 4 weeks for a first assessment. Diagnostic delays of 2 weeks or more can lead to a 20% decrease in 5-year-survival rates.

Skin Analytics supports NHS dermatology teams by creating patient pathways that leverage our AI as a Medical Device (AIaMD), DERM, to help triage patients to the right place at the right time.

Our typical pathway:

STEP 1

GP referral: GP refers to secondary care on the urgent suspected skin cancer pathway as normal

STEP 2

Image capture: Patients’ first appointments are at an imaging clinic, where consent, medical history, context and dermoscopic images are captured.

STEP 3

AI assessment: DERM assesses the dermoscopic images of lesions only.

STEP 4:

Next steps: Based on the outcome of the AI assessment, the case will be directed to the right level of care.

BENIGN: Patients are sent an outcome letter confirming the results and are discharged from the urgent suspected skin cancer pathway.#

PREMALIGNANT/ MALIGNANTA trust dermatologist will review the case virtually and decide on a management outcome which will then be communicated to the patient.

 

Proven experience with strong outcomes for our partners

At the end of Q4 2023, Skin Analytics had assessed over 81,000 NHS patients for suspicion of skin cancer. Our performance reporting shows our system consistently performs at a level comparable to specialists while reducing the number of urgent suspected cancer referrals dermatology teams need to review face to face.

View all Products
Loading

Sign up to our newsletter

Sign up for updates on the latest products, exhibitors and all the show news.